Predictors of Relapse and Functioning in First-Episode Psychosis: A Two-Year Follow-Up Study.

OBJECTIVE First-episode psychosis has an annual incidence rate of 24.6 to 40.9 per 100,000 population, and most individuals develop chronic disorders, such as schizophrenia or affective psychosis. The first two to five years are thought to be key determinants of long-term functional and clinical prognosis. This study aimed to determine the two-year course of illness in first-episode psychosis, including diagnosis, relapse, and functioning and factors related to these variables. METHODS A total of 140 patients who experienced a first episode of psychosis were recruited and evaluated between 2008 and 2012 in a first-episode psychosis program in Barcelona, Spain. Regression models were used to determine factors predicting relapse and functioning. RESULTS A general trend was noted toward improved functioning and less severe psychotic symptoms. However, after two years, one-third of the patients had a diagnosis of schizophrenia and more than 40% had a diagnosis of affective psychosis. Rates of relapse were 31% after one year and 43% at two years. Cannabis use after illness onset and poor insight were the best predictors of relapse. Being male and severity of negative symptoms at baseline predicted worse functioning at two years. CONCLUSIONS Patients with first-episode psychosis were found to have high relapse rates during the first years after illness onset. Further studies evaluating treatment strategies focused on reducing cannabis use and improving insight in first-episode psychosis should be encouraged.

[1]  G. Bond,et al.  Essential evidence-based components of first-episode psychosis services. , 2013, Psychiatric services.

[2]  K. Hill,et al.  The relationship between internalized stigma, negative symptoms and social functioning in schizophrenia: The mediating role of self-efficacy , 2013, Psychiatry Research.

[3]  O. Andreassen,et al.  Predictors of medication adherence in patients with schizophrenia and bipolar disorder , 2012, Acta psychiatrica Scandinavica.

[4]  L. Seidman,et al.  The nature and evolution of insight in schizophrenia: A multi-informant longitudinal study of first-episode versus chronic patients , 2008, Schizophrenia Research.

[5]  E. Chen,et al.  Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study , 2012, Psychological Medicine.

[6]  J. Vázquez-Barquero,et al.  Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study. , 2012, Journal of psychiatric research.

[7]  P. McGorry,et al.  Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies , 2012, Schizophrenia Research.

[8]  Robin M. Murray,et al.  Incidence of Schizophrenia and Other Psychoses in England, 1950–2009: A Systematic Review and Meta-Analyses , 2012, PloS one.

[9]  D. Addington,et al.  Validity of hospital admission as an outcome measure of services for first-episode psychosis. , 2012, Psychiatric services.

[10]  M. Lam,et al.  Persistent negative symptoms in first-episode schizophrenia: A prospective three-year follow-up study , 2011, Schizophrenia Research.

[11]  Molly A. Erickson,et al.  Insight and negative symptoms as predictors of functioning in a work setting in patients with schizophrenia , 2011, Psychiatry Research.

[12]  L. Nicole,et al.  [Specialised first-episode psychosis services: a systematic review of the literature]. , 2011, L'Encephale.

[13]  M. Figueira,et al.  [Early intervention in psychosis: first-episode psychosis and critical period]. , 2011, Acta medica portuguesa.

[14]  A. Malla,et al.  Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years. , 2010, Schizophrenia bulletin.

[15]  A. David,et al.  Outcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathology , 2010, British Journal of Psychiatry.

[16]  S. Hetrick,et al.  A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis , 2010, Schizophrenia Research.

[17]  M. Bell,et al.  Review on Vocational Predictors: A Systematic Review of Predictors of Vocational Outcomes Among Individuals with Schizophrenia: An Update Since 1998 , 2010, The Australian and New Zealand journal of psychiatry.

[18]  Jian Kang,et al.  Predictors of admission in first-episode psychosis: developing a risk adjustment model for service comparisons. , 2010, Psychiatric services.

[19]  S. Cooper,et al.  Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. , 2009, The British journal of psychiatry : the journal of mental science.

[20]  R. Boellaard,et al.  Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum , 2009, Neuropsychopharmacology.

[21]  J. Waddington,et al.  Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis , 2009, British Journal of Psychiatry.

[22]  C. García,et al.  [Spanish adaptation of the Scale to Asses Unawareness of Mental Disorder (SUMD)]. , 2008, Actas espanolas de psiquiatria.

[23]  P. McGorry,et al.  Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis. , 2007, The Journal of clinical psychiatry.

[24]  N. Tarrier,et al.  Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. , 2007, The Journal of clinical psychiatry.

[25]  B. V. Zwieten-Boot,et al.  ECNP consensus meeting. Negative, depressive and cognitive symptoms of schizophrenia. Nice, March 2004 , 2007, European Neuropsychopharmacology.

[26]  D. Wiersma,et al.  Guided Discontinuation Versus Maintenance Treatment in Remitted First-Episode Psychosis: Relapse Rates and Functional Outcome , 2007 .

[27]  J. Addington,et al.  One-Year Stability of Diagnosis in First-Episode Nonaffective Psychosis: Influence of Sex , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[28]  Peter B. Jones,et al.  Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study , 2006, Psychological Medicine.

[29]  R. Zipursky,et al.  A systematic review of longitudinal outcome studies of first-episode psychosis , 2006, Psychological Medicine.

[30]  Brian Kirkpatrick,et al.  The NIMH-MATRICS consensus statement on negative symptoms. , 2006, Schizophrenia bulletin.

[31]  S. Hutton,et al.  Comorbid substance use and age at onset of schizophrenia , 2006, British Journal of Psychiatry.

[32]  M. Lambert,et al.  Diagnostic stability 18 months after treatment initiation for first-episode psychosis. , 2005, The Journal of clinical psychiatry.

[33]  G. Krarup,et al.  A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness , 2005, BMJ : British Medical Journal.

[34]  M. Clarke,et al.  Diagnostic stability four years after a first episode of psychosis. , 2005, Psychiatric services.

[35]  S. Lewis,et al.  Duration of untreated psychosis and its relationship to clinical outcome , 2005, British Journal of Psychiatry.

[36]  M. Redoblado-Hodge,et al.  Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. , 2005, The Australian and New Zealand journal of psychiatry.

[37]  Peter B. Jones,et al.  Cannabis use and outcome of recent onset psychosis , 2005, European Psychiatry.

[38]  A. Malla,et al.  First-episode psychosis: psychopathology, quality of life, and functional outcome. , 2005, Schizophrenia bulletin.

[39]  E. Bromet,et al.  Long-term diagnostic stability and outcome in recent first-episode cohort studies of schizophrenia. , 2005, Schizophrenia bulletin.

[40]  L. San,et al.  Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia , 2004, Schizophrenia Research.

[41]  S. Sevy,et al.  The relationship between insight and symptoms in schizophrenia. , 2004, Comprehensive psychiatry.

[42]  J. Lieberman,et al.  Predictors of antipsychotic treatment response in patients with first episode schizophrenia, schizoaffective, and schizophreniform disorders , 2003, Schizophrenia Research.

[43]  Christian R. Dolder,et al.  Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. , 2002, The Journal of clinical psychiatry.

[44]  M. Salamero,et al.  Versión española de una escala de evaluación de la manía: validez y fiabilidad de la Escala de Young , 2002 .

[45]  R. Dal-Ré,et al.  Validación de las versiones en español de la Montgomery-Asberg Depression Rating Scale y la Hamilton Anxiety Rating Scale para la evaluación de la depresión y de la ansiedad , 2002 .

[46]  Emil Kraepelin,et al.  Dementia praecox and paraphrenia , 2002 .

[47]  Eduard Vieta,et al.  [Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale]. , 2002, Medicina clinica.

[48]  E. Laska,et al.  Recovery from psychotic illness: A 15- and 25-year international follow-up study , 2001, British Journal of Psychiatry.

[49]  R. Buchanan,et al.  A separate disease within the syndrome of schizophrenia. , 2001, Archives of general psychiatry.

[50]  J. Usall,et al.  [Gender differences in schizophrenia. A literature review]. , 2000, Actas espanolas de psiquiatria.

[51]  M. Birchwood,et al.  Early intervention in psychosis: the critical-period hypothesis , 1998 .

[52]  T. McGlashan,et al.  The Varied Outcomes of Schizophrenia , 1997, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[53]  P. Martín,et al.  Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients , 1994 .

[54]  P. Dingemans,et al.  Cannabis abuse and the course of recent onset schizophrenic disorders , 1993, Schizophrenia Research.

[55]  J. Sweeney,et al.  Drug abuse in schizophrenic patients: clinical correlates and reasons for use. , 1991, The American journal of psychiatry.

[56]  N. Smeeton,et al.  The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics. , 1989, Psychological medicine. Monograph supplement.

[57]  J. Fleiss,et al.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.